Product Data Sheet

DOTA-PEG4-OSu

Catalog No. A99297

main product photo
DOTA-PEG4-OSu is a bifunctional conjugate that combines a chelating agent with a PEG-based linker. It serves as a crucial intermediate for synthesizing radionuclide reagents, specifically 68Ga-DOTA-PEG4-(GGG-cKiE)2. This compound is instrumental in radiopharmaceutical applications, particularly in the development of targeted imaging agents for diagnostic purposes.
Chemical Information
Catalog NumA99297
M. Wt748.78
FormulaC31H52N6O15
Purity>98%
Storageat -20 °C 3 years (powder form); at -20 °C 6 months (Solution base)
CAS No.2417490-56-1
Synonyms
SMILESO=C(CN1CCN(CCN(CCN(CC1)CC(O)=O)CC(NCCOCCOCCOCCOCCC(ON2C(CCC2=O)=O)=O)=O)CC(O)=O)O
Biological Activity
DescriptionDOTA-PEG4-OSu is a bifunctional conjugate that combines a chelating agent with a PEG-based linker. It serves as a crucial intermediate for synthesizing radionuclide reagents, specifically 68Ga-DOTA-PEG4-(GGG-cKiE)2. This compound is instrumental in radiopharmaceutical applications, particularly in the development of targeted imaging agents for diagnostic purposes.
RETURN POLICY
Adooq’s Unconditional Return Policy ensures a smooth online shopping experience for our customers. If you are in any way unsatisfied with your purchase, you may return any item(s) within 7 days of receiving it. In the event of product quality issues, either protocol related or product related problems, you may return any item(s) within 365 days from the original purchase date. Please follow the instructions below when returning products.
SHIPPING AND STORAGE
Adooq products are transported at room temperature. If you receive the product at room temperature, please rest assured, the Adooq Quality Inspection Department has conducted experiments to verify that the normal temperature placement of one month will not affect the biological activity of powder products. After collecting, please store the product according to the requirements described in the datasheet. Most Adooq products are stable under the recommended conditions.